Affiliation:
1. Birla Institute of Technology and Science (BITS) Pilani, Hyderabad Campus
2. Puducherry Technological University (Erstwhile Pondicherry Engineering College)
Abstract
Antibiotics are playing crucial role in the treatment of humans since the last few centuries. Their usage has several benefits along with side effects. The efficacy of antibiotics for the treatment of ailments may be retained by controlling the drug dosage. This may be achieved with supercritical fluid technology (SFT). The antibiotic drug solubility in supercritical carbon dioxide (scCO2) is available only at specific temperature and pressure conditions, for effective utilization of SFT, solubility at various conditions are required. Equation of state (EoS) method is used for solubility data modeling and it requires critical properties of the solute, molar volume of the solute and sublimation pressure of the solute along with fugacity coefficient, pressure and temperature. These properties are estimated using group contribution methods. For antibiotics solute critical properties, molar volume and sublimation pressure are unavailable and existing group contribution methods are also not applicable due to the lack of functional group contributions in their techniques. Thus, there is a need to address EoS methodology without using solute properties. Hence, a new EoS methodology for solubility modeling is, proposed without using critical properties of the solute, molar volume of the solute and vapour pressure of the solute. Thus, this study focuses on the development of new solubility model that correlates antibiotics using equation of state (EoS). Importantly, the proposed solubility model does not use the critical properties of the antibiotics. Correlating ability of the proposed model is indicated in terms of regression coefficient and arithmetic average relative deviation percentage (AARD %).
Publisher
International Centre for Applied Thermodynamics (ICAT)
Reference36 articles.
1. A. Tabernero, E. M. del Valle and M. A. Galán, “Supercritical fluids for pharmaceutical particle engineering: Methods, basic fundamentals and modelling,” Chem. Eng. Process, vol. 60, pp. 9-25, October 2012. doi:10.1016/j.cep.2012.06.004.
2. B. Subramaniam, R.A. Rajewski and K. Snavely, “Pharmaceutical processing with supercritical carbon dioxide,” J. Pharm.Sci. vol. 86, no. 8, pp. 885-890, August 1997. doi:10.1021/js9700661.
3. M. Mukhopadhyay, “Partial molar volume reduction of solvent for solute crystallization using carbon dioxide as antisolvent,” J Supercrit Fluids, vol. 25, no. 3, pp. 213-223, April 2003. doi:10.1016/S0896-8446(02)00147-X.
4. N. Elvassore, I. Kikic, “Pharmaceutical processing with supercritical fluids,” In High Pressure Process Technology: Fundamentals and Applications, A. Bertucci, A. Better (Ed.,) Elsevier Science, 2001, pp 612-625.
5. R. B. Gupta and P. Chattopadhyay, “Method of forming nanoparticles and microparticles of controllable size using supercritical fluids and ultrasound,” US pat., 20020000681, March 2002.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献